Sullivan Mark

USNatural personOfficer

Insider

Sullivan Mark

USNatural personOfficer

Transactions

Issuers

Buys / Sells

0/15

Last tx

25 Mar 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Definium Therapeutics, Inc.	271,079	reported	25 Mar 2026	tx 12+600,000−78,126
Eleven Biotherapeutics, Inc.	198,716	reported	02 Mar 2023	tx 10+1,397,700−259,049
MedQuist Holdings Inc.	36,821	reported	14 Dec 2011	tx 8+45,492−8,397

Recent transactions

Date	Type	Issuer	Qty	Price
25 Mar 2026	SALE	Definium Therapeutics, Inc.	10,702	18.47 USD
03 Feb 2026	GRANT_AWARD	Definium Therapeutics, Inc.	125,000	0.00 USD
26 Dec 2025	SALE	Definium Therapeutics, Inc.	11,276	13.15 USD
25 Sept 2025	SALE	Definium Therapeutics, Inc.	11,278	9.77 USD
25 Jun 2025	SALE	Definium Therapeutics, Inc.	11,491

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Definium Therapeutics, Inc.	271,079	reported	25 Mar 2026	tx 12+600,000−78,126
Eleven Biotherapeutics, Inc.	198,716	reported	02 Mar 2023	tx 10+1,397,700−259,049
MedQuist Holdings Inc.	36,821	reported	14 Dec 2011	tx 8+45,492−8,397

Recent transactions

Date	Type	Issuer	Qty	Price
25 Mar 2026	SALE	Definium Therapeutics, Inc.	10,702	18.47 USD
03 Feb 2026	GRANT_AWARD	Definium Therapeutics, Inc.	125,000	0.00 USD
26 Dec 2025	SALE	Definium Therapeutics, Inc.	11,276	13.15 USD
25 Sept 2025	SALE	Definium Therapeutics, Inc.	11,278	9.77 USD
25 Jun 2025	SALE	Definium Therapeutics, Inc.	11,491